Laird Norton Wetherby Trust Company
RDY icon

Laird Norton Wetherby Trust Company’s Dr. Reddy's Laboratories RDY Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Sell
249,091
-23,395
-9% -$316K 0.07% 211
2026
Q1 		$3.77M Buy
272,486
+8,756
+3% +$122K 0.08% 195
2025
Q4 		$3.7M Buy
+263,730
New +$3.7M 0.08% 199

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Laird Norton Wetherby Trust Company's RDY Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Dr. Reddy's Laboratories (RDY) stake by 8.6% in Q2 2026, selling an estimated $316K and leaving 249,091 shares worth $3.61M. The position accounts for 0.07% of the portfolio, ranked #211.

Laird Norton Wetherby Trust Company first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.77M in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 249,091 shares of Dr. Reddy's Laboratories worth $3.61M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 23,395 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $316K.
  • Dr. Reddy's Laboratories made up 0.07% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #211 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's Dr. Reddy's Laboratories position peaked at $3.77M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.